Vera Therapeutics VERA Enterprise value

Enterprise value at other companies

Vertex PharmaceuticalsVRTX

$120.2B+7.2%

Travere Therapeutics, Inc.TVTX

$2.68B+65.5%

Aurinia PharmaceuticalsAUPH

$2.08B+83.9%

Climb Bio, Inc.CLYM

$319.33M+494%

Jade BiosciencesJBIO

$638.62M—

Viridian Therapeutics, Inc.VRDN

$1.98B+79.5%

FAQ

What is Vera Therapeutics's enterprise value?

Vera Therapeutics (VERA) reported enterprise value of $2.83B in Q1 2026.

How has Vera Therapeutics's enterprise value changed year-over-year?

Vera Therapeutics's enterprise value increased by 85.0% year-over-year, from $1.53B to $2.83B.

What is the long-term trend for Vera Therapeutics's enterprise value?

Over 4 years (2021 to 2025), Vera Therapeutics's enterprise value has grown at a 54.6% compound annual growth rate (CAGR), from $580.81M to $3.32B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.